Obesity treatment guidelines also recommend adjunct treatment with pharmacotherapies such as GLP-1 RAs when initial treatment through lifestyle interventions (nutrition, physical activity, and behavioral modifications) are unsuccessful [9,10,11,12]
November 15th, 2024: Master complaint filed in Ozempic MDL consolidating claims against Novo Nordisk and Eli Lilly The multidistrict litigation (MDL) for GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, reached a significant milestone with the filing of a Master Complaint
[6] [7] According to NICE guidance (NG28) on diabetes management, individualised treatment plans should balance glycaemic control with quality of life and safety considerations
Or feel free to give us a call at 424-600-8360
He has learned first-hand how some patients can struggle with weight gain and the difficulties they have losing weight
However, as medical experts point out, trends driven by social media often leapfrog ahead of the science